These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918 [TBL] [Abstract][Full Text] [Related]
4. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Taga T; Narazaki M; Yasukawa K; Saito T; Miki D; Hamaguchi M; Davis S; Shoyab M; Yancopoulos GD; Kishimoto T Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10998-1001. PubMed ID: 1438305 [TBL] [Abstract][Full Text] [Related]
5. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression. Westendorf JJ; Jelinek DF J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040 [TBL] [Abstract][Full Text] [Related]
7. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Benigni F; Fantuzzi G; Sacco S; Sironi M; Pozzi P; Dinarello CA; Sipe JD; Poli V; Cappelletti M; Paonessa G; Pennica D; Panayotatos N; Ghezzi P Blood; 1996 Mar; 87(5):1851-4. PubMed ID: 8634432 [TBL] [Abstract][Full Text] [Related]
8. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046 [TBL] [Abstract][Full Text] [Related]
9. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor. Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570 [TBL] [Abstract][Full Text] [Related]
10. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830 [TBL] [Abstract][Full Text] [Related]
11. gp130 Cytokine family and bone cells. Heymann D; Rousselle AV Cytokine; 2000 Oct; 12(10):1455-68. PubMed ID: 11023660 [TBL] [Abstract][Full Text] [Related]
12. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit. Modrell B; Liu J; Miller H; Shoyab M Growth Factors; 1994; 11(2):81-91. PubMed ID: 7857660 [TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor. Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331 [TBL] [Abstract][Full Text] [Related]
14. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex. Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501 [TBL] [Abstract][Full Text] [Related]
15. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Rowan AD; Koshy PJ; Shingleton WD; Degnan BA; Heath JK; Vernallis AB; Spaull JR; Life PF; Hudson K; Cawston TE Arthritis Rheum; 2001 Jul; 44(7):1620-32. PubMed ID: 11465713 [TBL] [Abstract][Full Text] [Related]
17. Gp130 in human myeloma/plasmacytoma. Tani Y; Nishimoto N; Ogata A; Shima Y; Yoshizaki K; Kishimoto T Curr Top Microbiol Immunol; 1995; 194():229-33. PubMed ID: 7895494 [No Abstract] [Full Text] [Related]
18. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404 [TBL] [Abstract][Full Text] [Related]
19. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein. Gimble JM; Wanker F; Wang CS; Bass H; Wu X; Kelly K; Yancopoulos GD; Hill MR J Cell Biochem; 1994 Jan; 54(1):122-33. PubMed ID: 8126083 [TBL] [Abstract][Full Text] [Related]
20. Interactions between oncostatin M and the IL-6 signal transducer, gp130. Liu J; Modrell B; Aruffo A; Scharnowske S; Shoyab M Cytokine; 1994 May; 6(3):272-8. PubMed ID: 8054483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]